SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-20970
COGENTIX MEDICAL, INC.
(Exact name of registrant as specified in its charter)
5420 Feltl Road
Minnetonka, Minnesota 554343
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, $0.01 par value
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Approximate number of holders of record as of the certification or notice date: One
Pursuant to the requirements of the Securities Exchange Act of 1934 Cogentix Medical, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|By:||/s/ Michael Frazzette|
|Title:||Chief Executive Officer|
Date: May 3, 2018